//./ActionParams/@language -> $page_language ->
The Economic Times
English EditionEnglish Editionहिन्दी
| 31 October, 2020, 01:06 AM IST | E-Paper
Search
+
    ENG
    • ENG - English
    • HIN - हिन्दी
    • GUJ - ગુજરાતી
    • MAR - मराठी
    • BEN - বাংলা 
    • KAN - ಕನ್ನಡ 
    • ORI - ଓଡିଆ
    • TEL - తెలుగు
    • TAM - தமிழ்

    AstraZeneca Pharma India Ltd.

    OPEN TRADING A/C
    • NSE
    • BSE
    Last Updated on 30 Oct, 2020, 03:50 PM IST
    4300.20

    Today's Change

    -70.70 (-1.62%)

    Volume
    AVERAGE VOLUME
    5-Day
    10-Day
    30-Day

    22,053

    Open

    4380.00

    Prev. Close

    4370.90

    Day's Trend

    Low
    4276.55
    High
    4427.45
    • Bid
    • Mkt Cap (₹ Cr.)
    • P/E (x)
    • P/B (x)
    • Div_ Yield (%)
    • BETA
      BETA
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    • Offer
    • Face Value (₹)2.00
    • EPS-TTM (Rs.)27.73
    • BV/share (₹)145.78
    • 52Wk L/H1885.00/ 4970.00
    • Avg. Daily Volatility %
      Avg. Daily Volatility %
      1 Month
      3-Months
      6-Months
      1 Year
      3-Years
    InsightsCandle Pattern| Events| Recos| Updates| News
    AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    AstraZeneca Pharma India Ltd.Board Meeting Intimation for Meeting Of The Board Of Directors Of The Company To Be Held On Thursday, November 5, 2020| Announcement
    AstraZeneca Pharma India Ltd.Shareholding for the Period Ended September 30, 2020| Announcement
    AstraZeneca Pharma India Ltd.Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018| Announcement
    AstraZeneca Pharma India Ltd.Certificate Under Regulation 40(10) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015| Announcement
    AstraZeneca Pharma India Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    AstraZeneca Pharma India Ltd.Launch Of Acalabrutinib 100Mg Capsules (Calquence?)| Announcement
    AstraZeneca Pharma India Ltd.Certificate Under Regulation 7(3) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015| Announcement
    AstraZeneca Pharma India Ltd.Statement Of Investor Complaints For The Quarter Ended September 2020| Announcement
    AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
    AstraZeneca Pharma India Ltd.Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate| Announcement
    AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation| Announcement
    AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Dividend Updates| Announcement
    AstraZeneca Pharma India Ltd.Astrazeneca Pharma India Limited Receives Import And Market Permission In Form CT-20 (Marketing Authorization) From Drug...| Announcement
    AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Newspaper Publication| Announcement
    AstraZeneca Pharma India Ltd.Announcement under Regulation 30 (LODR)-Change in Directorate| Announcement
    AstraZeneca Pharma India Ltd.Shareholder Meeting / Postal Ballot-Scrutinizers Report| Announcement
    AstraZeneca Pharma India Ltd.Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)| Announcement
    AstraZeneca Pharma India Ltd.Summary Of Proceedings Of 41St Annual General Meeting| Announcement
    AstraZeneca Pharma India Ltd.Fixes Record Date for Interim Dividend| Announcement
    AstraZeneca, STEMI India collaborate| News
    Fifteen stocks in focus in Monday morning trade| News
    AstraZeneca Q3 net profit at Rs 8.67 crore| News
    Sun Pharma, AstraZeneca seal distribution deal| News
    AstraZeneca Pharma surges on strong Q4 results| News

    AstraZeneca Pharma India Ltd. Share Price Updates

    AstraZeneca Pharma India Ltd. share price down by -1.62% from its previous close of Rs 4370.90. AstraZeneca Pharma India Ltd. stock last traded price is 4300.20
    AstraZeneca Pharma India Ltd. Share Price
    Value
    Today/Current/Last
    4300.20
    Previous Day
    4370.90
    What's your view on AstraZeneca Pharma India for the week?
    Bearish
    Bullish
    View community Outlook >>

    Be the first one to post on AstraZeneca Pharma India Ltd.

    AstraZeneca Pharma India Ltd.
    Quarterly Results

    Figures in Rs. Cr
    Jun 2020 
    % Chg (Quarterly)
    % Chg (Yearly)
    Peer Range
    Trend
    Last 12 Quarters Trend
    Sales
    193.58
    -0.68
    -5.37
    0.13
    1064.27
    Other Operating Income
    0.00
    0.00
    0.00
    0.00
    0.00
    Operating Profit
    28.57
    93.22
    -19.66
    -0.11
    774.92
    Other Income
    2.65
    -21.57
    -11.41
    0.00
    57.79
    EBITDA
    31.22
    71.88
    -19.02
    -0.11
    774.92
    Interest
    0.27
    2.82
    -7.28
    0.00
    4.45
    Depreciation
    4.56
    0.38
    -1.42
    0.01
    27.14
    Tax
    7.75
    105.34
    -36.03
    -0.36
    62.15
    Net Profit
    18.63
    94.55
    -13.39
    -0.93
    180.35
    EPS (₹)
    7.45
    94.52
    -13.47
    -0.88
    84.87

    AstraZeneca Pharma India Ltd Share Price

    Vs Peers
    Companies
    LTP
    Intraday
    1W %
    1M %
    1 QTR %
    1 YR %
    3 YR %
    5 Yr %
    Trend -
    D|M|Y
    4300.20
    -1.62
    1.45
    -0.08
    29.62
    58.60
    311.44
    265.00
    1464.75
    -1.05
    -2.62
    -7.01
    1.55
    -8.40
    14.62
    -11.50
    8000.25
    -0.14
    -5.07
    -7.41
    3.16
    21.11
    90.20
    75.82
    4984.95
    -1.01
    -2.63
    1.74
    17.85
    27.80
    184.94
    95.71
    15298.15
    0.91
    -2.09
    -7.21
    2.63
    28.31
    260.08
    174.12
    5140.85
    -0.97
    1.47
    2.83
    23.83
    8.08
    358.04
    565.27
    Top Loser for the period amongst the peers
    Top Gainer for the period amongst the peers

    AstraZeneca Pharma India Ltd Risk Return Comparison

    with peersNew

    AstraZeneca Pharma India Ltd
    Financial Comparison

    with peers
    Management Efficiency
    AstraZeneca Pharma India Ltd 
    peer Average
    Peer Range
    Trend
    Return on Equity (%)
    19.81
    12.58
    0.00
    28.03
    Return on Assets (%)
    10.22
    8.50
    -1.90
    21.61
    Return on capital Employed (%)
    19.19
    11.77
    -13.76
    33.12
    Fixed Assets Turnover (x)
    2.50
    1.36
    0.20
    2.50
    Profitability and Growth
    Gross Profit Margin (%)
    12.27
    12.79
    -5.25
    23.26
    Operating Profit Margin(%)
    14.51
    15.44
    3.25
    26.61
    Net Profit margin (%)
    8.68
    9.87
    -3.59
    23.66
    Financial Strength
    Liquidity
    Quick Ratio (x)
    1.26
    2.71
    0.14
    7.96
    Current Ratio (x)
    1.79
    3.23
    0.37
    8.87
    Cash ratio (x)
    0.74
    1.06
    0.01
    2.42
    Solvency
    Debt Equity Ratio (x)
    0.00
    0.41
    0.00
    3.21
    Coverage Ratios
    Cash flows to long term debt (x)
    0.00
    5.54
    0.00
    37.15
    Better performer than its peers on this ratioAverage performer than its peers on this ratioUnderperformer than its peers on this ratio

    AstraZeneca Pharma India Ltd Share Holding as on 30-09-2020

    CategoryNo. of sharesPercentage
    Promoters00.00
    ForeignInstitutions494,5881.98
    NBanksMutualFunds556,0412.22
    Others586,0572.34
    GeneralPublic4,586,74418.35
    FinancialInstitutions26,5700.11
    ForeignPromoter18,750,00075.00

    MF Ownership Of AstraZeneca Pharma India Ltd. Shares

    Fund Name
    Category
    No. of shares
    % Change in Shares (MOM basis)
    % of AUM
    Amount Invested (in ₹ Cr)
    Equity: ELSS
    281593
    -19.20%
    1.92%
    121.19
    Nippon India Small Cap Direct-G
    Portfolio as on 30-09-2020
    Equity: Small Cap
    200000
    -27.27%
    0.89%
    86.08
    Sundaram Small Cap Direct-G
    Portfolio as on 30-09-2020
    Equity: Small Cap
    30884
    0.00%
    1.25%
    13.29
    Equity: Sectoral-Pharma
    29153
    -37.59%
    0.63%
    12.55
    PGIM India Diversified Equity Direct-G
    Portfolio as on 30-09-2020
    Equity: Multi Cap
    7500
    100.00%
    1.15%
    3.23

    Liquid, Ultra Short Term funds and FMPs are not taken into account.

    More Schemes »

    About AstraZeneca Pharma India Ltd.

    AstraZeneca Pharma India Ltd., incorporated in the year 1979, is a Mid Cap company (having a market cap of Rs 10750.50 Crore) operating in Pharmaceuticals sector.

    AstraZeneca Pharma India Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 801.26 Crore to Sales Value (96.32 % of Total Sales), Sale of services which contributed Rs 30.51 Crore to Sales Value (3.66 % of Total Sales), Scrap which contributed Rs .04 Crore to Sales Value (0.00 % of Total Sales)for the year ending 31-Mar-2020.

    For the quarter ended 30-06-2020, the company has reported a Standalone sales of Rs 193.58 Crore, down -.68 % from last quarter Sales of Rs 194.90 Crore and down -5.37 % from last year same quarter Sales of Rs 204.56 Crore Company has reported net profit after tax of Rs 18.63 Crore in latest quarter.

    The company’s top management includes Mr.Gagandeep Singh Bedi, Mr.Ian John Parish, Mr.Narayan K Seshadri, Mr.Rajesh Marwaha, Ms.Kimsuka Narsimhan, Ms.Revathy Ashok, Ms.Weiying Sarah Wang. Company has Price Waterhouse & Co Chartered Accountants LLP as its auditors. As on 30-09-2020, the company has a total of 25,000,000 shares outstanding.

    Close X
    WatchlistPortfolio

    Current Price>: 2389.88

    Set Alert

    Loading
    Please wait...

    Date Sources:Live BSE and NSE Quotes Service: TickerPlant | Corporate Data, F&O Data & Historical price volume data: Dion Global Solutions Ltd.
    BSE Quotes and Sensex are real-time and licensed from the Bombay Stock Exchange. NSE Quotes and Nifty are also real time and licenced from National Stock Exchange. All times stamps are reflecting IST (Indian Standard Time).
    By using this site, you agree to the Terms of Service and Privacy Policy.

    The Economic Times

    Loadingdata
    More on:
    Prices| Financials | Company Info | Reports | News | Competitors